Executive team &
Strategic board
Strategic board members
Karim Ioualalen,
PhD, Founder CEO
Previously Chief Scientific Advisor at Pfizer Capsugel Laboratories and a specialist in formulation technologies, K. Ioualalen led the strategy and R&D for new drug delivery systems. He also developed numerous products in the PPI (proton pump inhibitors) and anticancer drug categories.
He served as Chief Scientific Officer at Oralance Pharma Laboratories, where he oversaw the transfer of the NODS technology to Pfizer, the global pharmaceutical leader. He has held various scientific leadership positions in several biotechnology companies and managed the establishment of a biological production line at the Saint Louis (US) site of the Sigma-Aldrich group.
Rosanne Raynal,
PhD, MBA Founder, CFO/COO
Rosanne Raynal was the President and CEO of Oralance Pharma, specializing in the formulation and development of new products that can be administered orally. She has extensive experience in financial management, fundraising, biotech project management and technology transfer. she oversaw the transfer of the NODS technology to Pfizer,
Specialist in biopolymers, she began her career at BIOEUROPE S.A. as head of the management of European projects and programmes. She has led the industrial exploitation of a new class of biotechnological products at ARD Biotechnologies
Jacques Chevallet,
PharmD
Jacques Chevallet was the President and CEO of ArkoPharma, a company of the Dermapharm Group.
Previously AMERICAS & ASIA PACIFIC Region manager of Pierre Fabre Laboratories and General Manager SERVIER FINLAND
Ludovic Robin,
PharmD
Ludovic Robin was Chief Business & Strategy Officer of Advicenne Pharma. Previously, Commercial Operations Head France & BeNeLux of Shire Pharmaceuticals company
In charge of the nephrology, haematology, gastro and neurosciences portfolio
Operations team
Cloé Fabre,
Engineer MsC
Head R&D Pharmaceutical Process
GMP Production Management
Jessica Tran,
Engineer MsC
​
Head R&D Clinical
CRO, CDMO Partnerships
Alexis Bages, PhD
​
Head R&D Biological products
Drug delivery systems, Oral formulations
Pascal BOUR,
Quality officer - QM Services
​
Pascal Bour is graduated from the University of Metz. He has held different positions as Head of QC and QA/QP at various companies in Switzerland. He is registred at Swissmedic as FVP and is a certified GMP auditor. Pascal has a wide experience of product release and IMP for clinical studies.
La politique RSE
Institutional laboratories
Institutional partners
Eneapharm a également développé des collaborations avec des partenaires privés.
CSR policy
Eneapharm is committed to a systematic approach and organization that supports its quality management system. To this end, it wishes to implement a certification process for its main processes, and in particular:
•Compliance with European and French bioethics rules
•Compliance with scientific experimentation legislation
•Reduction of environmental impacts from manufacturing processes
•The CSR approach is established as a fundamental value of strategy management
​
At this stage, Eneapharm distinguishes different stakeholders, including shareholders and steering committees, the board of directors, the strategic committee, and the scientific committee, associations and NGOs, participation in the life of local or national bodies, employees and collaborators of the company, suppliers, public authorities.